Duloxetine + Warfarin
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anticoagulant Effect of Warfarin When Taken With Duloxetine.
Conditions
Anticoagulant Effect of Warfarin When Taken With Duloxetine.
Trial Timeline
Jul 1, 2007 → Oct 1, 2007
NCT ID
NCT00533026About Duloxetine + Warfarin
Duloxetine + Warfarin is a phase 1 stage product being developed by Eli Lilly for Anticoagulant Effect of Warfarin When Taken With Duloxetine.. The current trial status is completed. This product is registered under clinical trial identifier NCT00533026. Target conditions include Anticoagulant Effect of Warfarin When Taken With Duloxetine..
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00533026 | Phase 1 | Completed |
Competing Products
2 competing products in Anticoagulant Effect of Warfarin When Taken With Duloxetine.
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Andexanet alfa + 4F-PCC | AstraZeneca | Pre-clinical | 26 |
| Anticoagulant | AstraZeneca | Pre-clinical | 22 |